Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Hepatobiliary Diseases News

News
Imaging, Biomarkers May Improve Hepatocellular Carcinoma Surveillance
03/30/2023
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and...
03/30/2023
Gastroenterology
News
Gastrointestinal, Hepatic Manifestations Affect Many with COVID-19
03/02/2023
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause...
03/02/2023
Gastroenterology
News
HIMALAYA Trial Examines Treatment-Emergent ADAs for Durvalumab in HCC Regimens
02/24/2023
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may...
02/24/2023
Gastroenterology

Advertisement

News
Biomarkers To Predict ICI Response in Hepatobiliary Cancers “Urgently” Needed
02/08/2023
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates...
02/08/2023
Gastroenterology
News
Durvalumab Plus Tremelimumab Improves Survival in Unresectable HCC
01/17/2023
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab...
01/17/2023
Gastroenterology
News
Disparities in Access to Immunotherapy for HCC
01/13/2023
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are...
01/13/2023
Gastroenterology

Advertisement

News
Patient-Reported Barriers to HCC Surveillance
01/04/2023
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in...
01/04/2023
Gastroenterology
News
Robotic Liver Resection for Hepatocellular Carcinoma Offers Oncologic Efficacy, Safety
12/28/2022
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers...
12/28/2022
Gastroenterology
News
CCA Diagnostic Tools Reviewed for Comparative Sensitivity
12/19/2022
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of...
12/19/2022
Gastroenterology

Advertisement

News
Did the Pandemic Affect HCC Surveillance?
11/29/2022
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find...
11/29/2022
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
Novel AI System Shows Success in Detection of Adenomas
08/27/2024
CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.
CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.
CAD-EYE detection system...
08/27/2024
Gastroenterology
News
Implementation of Fecal Immunochemical Test-Based Program in Colorectal Cancer Screening
08/20/2024
Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.
Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.
Investigators studied whether...
08/20/2024
Gastroenterology
News
Low-Dose Aspirin and Prevention of Colorectal Cancer
08/14/2024
Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.
Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.
Results of a new study showed...
08/14/2024
Gastroenterology
News
FIT Screening Associated With Lower Risk of Death From CRC
08/06/2024
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support...
08/06/2024
Gastroenterology
FDA
News
FDA Approves First Blood Test for Primary CRC Screening
07/30/2024
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test...
07/30/2024
Gastroenterology
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Ultraprocessed Food Linked to Elevated Risk of CRC
07/24/2024
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon...
07/24/2024
Gastroenterology
FDA alert
News
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
06/28/2024
The device can provide results in an hour from a fingertip blood test.
The device can provide results in an hour from a fingertip blood test.
The device can provide results...
06/28/2024
Gastroenterology
FDA alert
FDA Alert
Elafibranor Receives Accelerated FDA Approval for PBC
06/14/2024
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the...
06/14/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use